Landmark septic shock trial provides new evidence for emergency care
By Alicia Bienkowski | Centre for Clinical Research in Emergency Medicine, SepsisResearchers from the Perkins Centre for Clinical Research in Emergency Medicine (CCREM) have helped deliver important new evidence that could influence the treatment of septic shock around the world. The…
Professor Shirley Jansen AM recognised for outstanding service to vascular surgery and medical research
By Alicia Bienkowski | Cardiovascular Disease, Media Releases, News & Events, Targeted Drug DeliveryWestern Australia-based vascular surgeon and researcher Professor Shirley Jansen has been appointed a Member of the Order of Australia (AM) in recognition of her significant service to vascular surgery as…
Funding boost to supercharge medical research and innovation
By Richard Schoonraad | APEXHeart Lab, Cardiovascular Disease, Cardiovascular Disease, Cardiovascular Research & Innovation, Funding, Molecular Endocrinology and Pharmacology, News & Events, StatementsTwo Perkins researchers received funding from the Future Health Research and Innovation Fund through the Enabling Scheme and the Research and Innovation Capacity and Capability Building Program last week. Professor…
Recognition for respected vascular specialist
By Richard Schoonraad | awards, Cardiovascular Disease, Cardiovascular Disease, Cardiovascular Science and Diabetes Program, Heart, Imaging and Therapy, News & Events, ResearchDirector of the Heart and Vascular Research Institute and Joint Program Head of the Cardiovascular Science and Diabetes Program at the Harry Perkins Medical Research Institute, Professor Shirley Jansen has…
Researchers develop new AI tool to predict heart attack risk
By Richard Schoonraad | Cardiovascular Disease, Cardiovascular Research & Innovation, Cardiovascular Science and Diabetes Program, Heart, News & EventsResearchers from the Harry Perkins Institute of Medical Research, working with medtech industry partners Artrya Limited, have developed a new, fully-automated AI algorithm that is more effective than current methods…
Perkins researchers put paid to plaque in arteries
By Richard Schoonraad | Blood Vessels, Cardiovascular Disease, Cardiovascular Disease, Cardiovascular Science and Diabetes Program, Cell Signalling, Donation Handles, Funding, Heart, Imaging and Therapy, Media Releases, News & Events, Research, Sarcoma, Targeted Drug Delivery, TreatmentsThe Harry Perkins Institute of Medical Research is celebrating a major milestone in the progression of a world-first drug candidate that has the potential to change the lives of thousands…
Perkins partners with Victor Chang Cardiac Research Institute for better heart outcomes
By Richard Schoonraad | APEXHeart Lab, Cardiovascular Disease, Cell Signalling, Community, Donation Handles, Media Releases, News & Events, Research, SarcomaThe Harry Perkins Institute of Medical Research has forged a new partnership with one of Australia’s leaders in heart research. The strategic partnership with the Victor Chang Cardiac Research Institute…
New heart health trial targets families with history of early heart attacks
By Richard Schoonraad | Cardiovascular Research & Innovation, Cardiovascular Science and Diabetes Program, Cell Signalling, Community, Donation Handles, Heart, News & Events, Research, SarcomaA pioneering new study led by cardiologist Associate Professor Abdul Ihdayhid from the Harry Perkins Institute of Medical Research and Curtin University is offering new hope to families affected by…